ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 175 filers reported holding ANTARES PHARMA INC in Q4 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $35,436,000 | +17.5% | 8,643,155 | +2.3% | 0.00% | 0.0% |
| Q4 2021 | $30,162,000 | -3.7% | 8,448,987 | -1.9% | 0.00% | 0.0% |
| Q3 2021 | $31,335,000 | -13.0% | 8,608,658 | +4.2% | 0.00% | 0.0% |
| Q2 2021 | $36,024,000 | +5.7% | 8,262,160 | -0.4% | 0.00% | 0.0% |
| Q1 2021 | $34,090,000 | +5.4% | 8,294,816 | +2.3% | 0.00% | 0.0% |
| Q4 2020 | $32,349,000 | +50.6% | 8,107,555 | +1.9% | 0.00% | 0.0% |
| Q3 2020 | $21,475,000 | -3.2% | 7,953,708 | -1.4% | 0.00% | 0.0% |
| Q2 2020 | $22,192,000 | +19.0% | 8,069,904 | +2.1% | 0.00% | 0.0% |
| Q1 2020 | $18,649,000 | -49.7% | 7,901,977 | +0.2% | 0.00% | 0.0% |
| Q4 2019 | $37,083,000 | +41.0% | 7,890,008 | +0.3% | 0.00% | 0.0% |
| Q3 2019 | $26,309,000 | +7.8% | 7,865,290 | +6.0% | 0.00% | 0.0% |
| Q2 2019 | $24,409,000 | +10.2% | 7,419,037 | +1.5% | 0.00% | 0.0% |
| Q1 2019 | $22,145,000 | +15.4% | 7,308,604 | +3.6% | 0.00% | 0.0% |
| Q4 2018 | $19,187,000 | -12.0% | 7,054,381 | +8.7% | 0.00% | 0.0% |
| Q3 2018 | $21,798,000 | +31.9% | 6,487,465 | +1.3% | 0.00% | 0.0% |
| Q2 2018 | $16,521,000 | +20.4% | 6,403,284 | +2.7% | 0.00% | 0.0% |
| Q1 2018 | $13,723,000 | +13.7% | 6,237,902 | +2.8% | 0.00% | 0.0% |
| Q4 2017 | $12,073,000 | -39.4% | 6,067,039 | -1.3% | 0.00% | 0.0% |
| Q3 2017 | $19,917,000 | -0.0% | 6,147,211 | -0.6% | 0.00% | 0.0% |
| Q2 2017 | $19,920,000 | +24.8% | 6,186,232 | +10.1% | 0.00% | 0.0% |
| Q1 2017 | $15,958,000 | +27.1% | 5,619,088 | +4.3% | 0.00% | 0.0% |
| Q4 2016 | $12,551,000 | +38.3% | 5,386,739 | -0.3% | 0.00% | 0.0% |
| Q3 2016 | $9,074,000 | +69.4% | 5,401,240 | +5.8% | 0.00% | – |
| Q2 2016 | $5,358,000 | +13.5% | 5,102,958 | -5.9% | 0.00% | – |
| Q1 2016 | $4,720,000 | -25.7% | 5,424,165 | +3.3% | 0.00% | – |
| Q4 2015 | $6,352,000 | -97.8% | 5,249,328 | -69.4% | 0.00% | -100.0% |
| Q3 2015 | $288,842,000 | +2865.2% | 17,151,151 | +266.2% | 0.01% | +1000.0% |
| Q2 2015 | $9,741,000 | -15.6% | 4,682,968 | +10.0% | 0.00% | 0.0% |
| Q1 2015 | $11,535,000 | +13.3% | 4,256,432 | +7.5% | 0.00% | 0.0% |
| Q4 2014 | $10,177,000 | +47.0% | 3,959,762 | +4.7% | 0.00% | 0.0% |
| Q3 2014 | $6,922,000 | -33.1% | 3,782,047 | -2.4% | 0.00% | 0.0% |
| Q2 2014 | $10,349,000 | -21.6% | 3,875,750 | +2.8% | 0.00% | 0.0% |
| Q1 2014 | $13,196,000 | -17.3% | 3,770,476 | +5.9% | 0.00% | 0.0% |
| Q4 2013 | $15,948,000 | +15.4% | 3,559,859 | +4.6% | 0.00% | 0.0% |
| Q3 2013 | $13,815,000 | -0.6% | 3,402,887 | +1.9% | 0.00% | 0.0% |
| Q2 2013 | $13,893,000 | – | 3,339,806 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 500,000 | $2,180,000 | 4.34% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,535,727 | $11,056,000 | 3.87% |
| Sargent Investment Group, LLC | 3,596,250 | $15,680,000 | 3.72% |
| Rubric Capital Management LP | 9,500,000 | $41,420,000 | 2.61% |
| PERKINS CAPITAL MANAGEMENT INC | 541,783 | $2,362,000 | 1.34% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,900,000 | $8,284,000 | 1.14% |
| Venator Capital Management Ltd. | 709,700 | $3,094,000 | 1.05% |
| LEVEL FOUR FINANCIAL, LLC | 120,000 | $523,000 | 0.22% |
| OBERWEIS ASSET MANAGEMENT INC/ | 200,600 | $875,000 | 0.19% |
| Brown Advisory Securities, LLC | 275,000 | $1,199,000 | 0.19% |